Production of soluble recombinant proteins with Kell, Duffy and Lutheran blood group antigen activity, and their use in screening human sera for Kell, Duffy and Lutheran antibodies

Transfusion Medicine

Volumn 17, Issue 5, 2007, Pages 384-394

  Ridgwell, K ^a   Dixey, J ^a   Scott, M L ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Antibody screening; Solid phase ELISA; Soluble recombinant blood group antigens

Indexed keywords

ANTIBODY; ANTIGEN; DUFFY ANTIBODY; KELL ANTIBODY; LUTHERAN ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BLOOD; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP LUTHERAN SYSTEM; BLOOD TRANSFUSION; COOMBS TEST; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; HEMAGGLUTINATION INHIBITION; HEMOLYTIC ANEMIA; HUMAN; NONHUMAN; PREGNANCY; RISK; SERUM;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; BLOOD GROUP ANTIGENS; CERCOPITHECUS AETHIOPS; COOMBS' TEST; COS CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; RECOMBINANT PROTEINS;

EID: 34848839586     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2007.00762.x     Document Type: Article

References (57)

1. Ahaded, A., Brossard, Y., Debbia, M. Lambin, P 2000) Quantitative determination of anti-K (KEL1) IgG and IgG subclasses in the serum of severely alloimmunized pregnant women by ELISA. Transfusion, 40, 1239 1245.
2. Avent, N.D 1997) Human erythrocyte antigen expression: its molecular bases. British Journal of Biomedical Science, 54, 16 37.
3. Banks, J., Poole, J., Ahrens, N. et al 2004) SERF: a new antigen in the Cromer blood group system. Transfusion Medicine, 14, 313 318.
4. BCSH (1996) Guidelines for blood grouping and red cell antibody testing during pregnancy. British Committee for Standards in Haematology, Blood Transfusion Task Force. Transfusion Medicine, 6, 71 74.
5. Boulton, F.E 1990) No clinical effect of Lutheran antibodies on a susceptible neonate. Vox Sanguinis, 59, 61.
6. Boyland, I.P., Mufti, G.J. Hamblin, T.J 1982) Delayed hemolytic transfusion reaction caused by anti-Fyb in a splenectomized patient. Transfusion, 22, 402.
7. Bruce, M., Chapman, J.F., Duguid, J., Kelsey, P., Knowles, S., Murphy, M. Williamson, L 1999) Addendum for guidelines for blood grouping and red cell antibody testing during pregnancy. BCSH Transfusion Task Force. Transfusion Medicine, 9, 99.
8. Campbell, I.G., Foulkes, W.D., Senger, G., Trowsdale, J., Garin-Chesa, P. Rettig, W.J 1994) Molecular cloning of the B-CAM cell surface glycoprotein of epithelial cancers: a novel member of the immunoglobulin superfamily. Cancer Research, 54, 5761 5765.
9. Cartron, J.P., Bailly, P., Le Van, K.C., Cherif-Zahar, B., Matassi, G., Bertrand, O. Colin, Y 1998) Insights into the structure and function of membrane polypeptides carrying blood group antigens. Vox Sanguinis, 74 (Suppl. 2 29 64.
10. Cesbron-Gautier, A., Simon, P., Achard, L., Cury, S., Follea, G. Bignon, J.D 2004) [Luminex technology for HLA typing by PCR-SSO and identification of HLA antibody specificities]. Annales de Biologie Clinique (Paris), 62, 93 98.
11. Chapman, J.F., Elliott, C., Knowles, S.M., Milkins, C.E. Poole, G.D 2004) Guidelines for compatibility procedures in blood transfusion laboratories. Transfusion Medicine, 14, 59 73.
12. Chaudhuri, A., Nielsen, S., Elkjaer, M.L., Zbrzezna, V., Fang, F. Pogo, A.O 1997) Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood, 89, 701 712.
13. Cowles, J.W. Blumberg, N 1987) Neutralization of P blood group antibodies by synthetic solid-phase antigens. Transfusion, 27, 272 275.
14. Daniels, G 2002) Human Blood Groups (2nd edn). Blackwell, Oxford.
15. Daniels, G., Flegel, W.A., Fletcher, A. et al 2007) International Society of Blood Transfusion Committee on Terminology for Red Cell Surface Antigens: Cape Town report. Vox Sanguinis, 92, 250 253.
16. Daniels, G., Hadley, A. Green, C.A 2003) Causes of fetal anemia in hemolytic disease due to anti-K. Transfusion, 43, 115 116.
17. Daniels, G.L., Green, C.A., Powell, R.M. Ward, T 1998) Hemagglutination inhibition of Cromer blood group antibodies with soluble recombinant decay-accelerating factor. Transfusion, 38, 332 336.
18. Diedrich, B., Andersson, J., Sallander, S. Shanwell, A 2001) K, Fy(a), and Jk(a) phenotyping of donor RBCs on microplates. Transfusion, 41, 1263 1267.
19. Dube, V.E. Zoes, C.S 1982) Subclinical hemolytic disease of the newborn associated with IgG anti-Lub. Transfusion, 22, 251 253.
20. El Nemer, W., Gane, P., Colin, Y., Bony, V., Rahuel, C., Galacteros, F., Cartron, J.P., Le Van Kim, C 1998) The Lutheran blood group glycoproteins, the erythroid receptors for laminin, are adhesion molecules. J Biol Chem, 273, 16686 16693.
21. El Nemer, W., Rahuel, C., Colin, Y., Gane, P., Cartron, J.P. Le Van, K.C 1997) Organization of the human LU gene and molecular basis of the Lu(a)/Lu(b) blood group polymorphism. Blood, 89, 4608 4616.
22. Fulton, R.J., McDade, R.L., Smith, P.L., Kienker, L.J. Kettman, J.R. Jr. 1997) Advanced multiplexed analysis with the FlowMetrix system. Clinical Chemistry, 43, 1749 1756.
23. Goodrick, M.J., Hadley, A.G. Poole, G 1997) Haemolytic disease of the fetus and newborn due to anti-Fy(a) and the potential clinical value of Duffy genotyping in pregnancies at risk. Transfusion Medicine, 7, 301 304.
24. Inderbitzen, P.E. Windle, B 1982) An example of HDN probably due to anti-Lua. Transfusion, 22, 542.
25. Iwamoto, S., Li, J., Omi, T., Ikemoto, S. Kajii, E 1996) Identification of a novel exon and spliced form of Duffy mRNA that is the predominant transcript in both erythroid and postcapillary venule endothelium. Blood, 87, 378 385.
26. Iwamoto, S., Omi, T., Kajii, E. Ikemoto, S 1995) Genomic organization of the glycoprotein D gene: Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood, 85, 622 626.
27. Kikkawa, Y., Moulson, C.-L., Virtanen, I., Miner, J.H 2002) Identification of the binding site for the Lutheran blood group glycoprotein on laminin alpha 5 through expression of chimeric laminin chains in vivo. J Biol Chem, 277, 44864 44869.
28. Kimura, S., Yurugi, K., Segawa, H. et al 2005) Rapid quantitation of immunoglobulin G antibodies specific for blood group antigens A and B by surface plasmon resonance. Transfusion, 45, 56 62.
29. Lee, S 1997) Molecular basis of Kell blood group phenotypes. Vox Sanguinis, 73, 1 11.
30. Lee, S., Lin, M., Mele, A., Cao, Y., Farmar, J., Russo, D., Redman, C 1999) Proteolytic processing of big endothelin-3 by the Kell blood group protein. Blood, 94, 1440 1450.
31. Mallinson, G., Soo, K.S., Schall, T.J., Pisacka, M. Anstee, D.J 1995) Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. British Journal of Haematology, 90, 823 829.
32. Million, L., Pellerin, C., Marchand-Arvier, M. Vigneron, C 1998) A stable reagent system for screening and identifying red blood cell irregular antibodies: application to commercial antibodies. Vox Sanguinis, 75, 288 297.
33. Moulds, J.M. Rowe, K.E 1996) Neutralization of Knops system antibodies using soluble complement receptor 1. Transfusion, 36, 517 520.
34. Muro, M., Llorente, S., Marin, L., Moya-Quiles, M.R., Gonzalez-Soriano, M.J., Prieto, A., Gimeno, L. Alvarez-Lopez, M.R 2005) Acute vascular rejection mediated by HLA antibodies in a cadaveric kidney recipient: discrepancies between FlowPRA, ELISA and CDC vs luminex screening. Nephrology Dialysis Transplantation, 20, 223 226.
35. Parsons, S.F., Lee, G., Spring, F.A., Willig, T.-N., Peters, L.L., Gimm, J.A., Tanner, M.J.A., Mohandas, N., Anstee, D.J., Chasis, J.A 2001) Lutheran blood group glycoprotein and its newly characterized mouse homologue specifically bind α5 chain-containing human laminin with high affinity. Blood, 97, 312 320.
36. Parsons, S.F., Mallinson, G., Holmes, C.H. et al 1995) The Lutheran blood group glycoprotein, another member of the immunoglobulin superfamily, is widely expressed in human tissues and is developmentally regulated in human liver. Proceedings of the National Academy of Science of the United States of America, 92, 5496 5500.
37. Reid, M.E. Lomas-Francis, C 2004) The Blood Group Antigens Factsbook (2nd edn). Academic Press, London.
38. Russo, D., Wu, X., Redman, C.M. Lee, S 2000) Expression of Kell blood group protein in nonerythroid tissues. Blood, 96, 340 346.
39. Russo, D.C., Lee, S., Reid, M. Redman, C.M 1994) Topology of Kell blood group protein and the expression of multiple antigens by transfected cells. Blood, 84, 3518 3523.
40. Schawalder, A., Reid, M.E. Yazdanbakhsh, K 2004) Recombinant glycophorins C and D as tools for studying Gerbich blood group antigens. Transfusion, 44, 567 574.
41. Scott, M.L., Guest, A.G. Rodkey, L.S 1997). Cytoskeletal extracts from Triton X-100 treated red cell membrane preparations show Rh and Jk blood group activity. Transfusion Medicine, 7, 29.
42. Sheffield, W.P., Bhakta, V. Denomme, G.A 2003) Use of recombinant forms of Duffy blood group antigen to detect anti-Fy(a) and anti-Fy(b) antibodies. Transfusion, 43, 34A.
43. Simmons, D.L 1993) Cellular Interactions in Development: A Practical Approach. IRL Press, Oxford.
44. Smythe, J.S. Anstee, D.J 2001) Expression of C antigen in transduced K562 cells. Transfusion, 41, 24 30.
45. Smythe, J.S., Avent, N.D., Judson, P.A., Parsons, S.F., Martin, P.G. Anstee, D.J 1996) Expression of RHD and RHCE gene products using retroviral transduction of K562 cells establishes the molecular basis of Rh blood group antigens. Blood, 87, 2968 2973.
46. Sosler, S.D., Perkins, J.T., Fong, K. Saporito, C 1989) The prevalence of immunization to Duffy antigens in a population of known racial distribution. Transfusion, 29, 505 507.
47. Spitalnik, S.L., Cowles, J.W., Cox, M.T. Blumberg, N 1983) Neutralization of Lewis blood group antibodies by synthetic immunoadsorbents. American Journal of Clinical Pathology, 80, 63 65.
48. Storry, J.R., Sausais, L., Hue-Roye, K. et al 2003) GUTI: a new antigen in the Cromer blood group system. Transfusion, 43, 340 344.
49. Tamai, T. Mazda, T 1999) A method for drying red blood cells for solid-phase immunoassay. Transfusion Medicine, 9, 343 349.
50. Telen, M.J., Rao, N., Udani, M., Thompson, E.S., Kaufman, R.M. Lublin, D.M 1994) Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology. Blood, 84, 3205 3211.
51. Tournamille, C., Le Van, K.C., Gane, P., Cartron, J.P. Colin, Y 1995) Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism. Human Genetics, 95, 407 410.
52. Vaughan, J.I., Manning, M., Warwick, R.M., Letsky, E.A., Murray, N.A. Roberts, I.A 1998) Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. New England Journal of Medicine, 338, 798 803.
53. Vescio, L.A., Farina, D., Rogido, M. Sola, A 1987) Hemolytic disease of the newborn caused by anti-Fyb. Transfusion, 27, 366.
54. Williams, D., Johnson, C.L. Marsh, W.L 1981) Duffy antigen changes on red blood cells stored at low temperature. Transfusion, 21, 357 359.
55. Yared, M.A., Moise, K.J. Rodkey, L.S 1997) Stable solid-phase Rh antigen. Transfusion Medicine, 7, 311 317.
56. Yazdanbakhsh, K., Oyen, R., Yu, Q., Lee, S., Antoniou, M., Chaudhuri, A. Reid, M.E 2000) High-level, stable expression of blood group antigens in a heterologous system. American Journal of Hematology, 63, 114 124.
57. Zen, Q., Batchvarova, M., Twyman, C.A., Eyler, C.E., Qiu, H., De Castro, L.M. Telen, M.J 2004) B-CAM/LU expression and the role of B-CAM/LU activation in binding of low- and high-density red cells to laminin in sickle cell disease. American Journal of Hematology, 75, 63 72.